Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656318 · ClinicalTrials.gov registry record
Impact of Oral Contraceptives on GABA and Neurosteroids
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 6
- Enrollment target
NCT00656318 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 6 participants.
The verdict
NCT00656318 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Thus, the proposed study has the following Specific Aims and Hypotheses: 1. To determine in menstruating women ages 18-45 whether an OCP containing ethinyl estradiol (EE) and the progestin ethinydiol diacetate (ED) increases cortical GABA concentrations as measured using proton magnetic resonance spectroscopy (1H-MRS) above that of an OCP containing EE and the progestin norethindrone (NOR). 2. To determine the relationship between changes in occipital GABA concentrations with acute OCP administration and negative affect with chronic OCP administration over two menstrual cycles.
Interventions
- OTHER oral contraceptive pill (OCP; OCPs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00656318
The ClinicalTrials.gov registry entry for NCT00656318 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral contraceptive pill (OCP; OCPs) is the first listed.
NCT00656318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00656318 about?
NCT00656318 is a clinical study titled "Impact of Oral Contraceptives on GABA and Neurosteroids". Thus, the proposed study has the following Specific Aims and Hypotheses: 1. To determine in menstruating women ages 18-45 whether an OCP containing ethinyl estradiol (EE) and the progestin ethinydiol diacetate (ED) increases cortical GABA concentrations as measured using proton magnetic resonance s...
What is the current status of trial NCT00656318?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2008-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00656318?
The interventions under investigation include: oral contraceptive pill (OCP; OCPs) (OTHER).
Who is sponsoring clinical trial NCT00656318?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.